Toni Choueiri describes the results of this renal cancer trial exploring rechallange with immune therapy

Episode 246: ASCO 2023: EV pembro and erdafitinib +/- cetrelimab in 1st line UC

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London